BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1877667)

  • 21. Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms.
    Khalil A; Carrier M; Latour JG; Pelletier LC
    Circulation; 1996 Nov; 94(9 Suppl):II308-11. PubMed ID: 8901766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow-mediated dilation attenuates constriction of large coronary arteries to serotonin.
    Lamping KG; Dole WP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1317-24. PubMed ID: 3144185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelium-mediated regulation of coronary tone.
    Bassenge E
    Basic Res Cardiol; 1991; 86 Suppl 2():69-76. PubMed ID: 1953618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NG-monomethyl-L-arginine paradoxically relaxes preconstricted canine intrapulmonary arteries.
    Tseng CM; Goodman LW; Rubin LJ; Tod ML
    J Appl Physiol (1985); 1993 Feb; 74(2):549-58. PubMed ID: 8458770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs.
    Okumura M; Miura K; Yamashita Y; Yukimura T; Yamamoto K
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1262-7. PubMed ID: 1545391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylcholine increases pulmonary blood flow in intact fetuses via endothelium-dependent vasodilation.
    Tiktinsky MH; Cummings JJ; Morin FC
    Am J Physiol; 1992 Feb; 262(2 Pt 2):H406-10. PubMed ID: 1539700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow.
    Natori Y; Moriguchi M; Fujiwara S; Takeshita I; Fukui M; Iwaki T; Kanaide H
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):120-7. PubMed ID: 1727133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N omega-nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs.
    Nishiwaki K; Nyhan DP; Rock P; Desai PM; Peterson WP; Pribble CG; Murray PA
    Am J Physiol; 1992 May; 262(5 Pt 2):H1331-7. PubMed ID: 1590434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of nitric oxide in regulation of basilar artery tone in vivo.
    Faraci FM
    Am J Physiol; 1990 Oct; 259(4 Pt 2):H1216-21. PubMed ID: 2121050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
    Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
    J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of cerebral arterial tone by endothelium-derived relaxing factor.
    Brian JE; Kennedy RH
    Am J Physiol; 1993 Apr; 264(4 Pt 2):H1245-50. PubMed ID: 8476102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats.
    Liu SF; Crawley DE; Barnes PJ; Evans TW
    Am Rev Respir Dis; 1991 Jan; 143(1):32-7. PubMed ID: 1986681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of endothelium-derived relaxing factor and prostaglandins in responses of coronary arteries to thromboxane in vivo.
    Szwajkun K; Lamping KG; Dole WP
    Circ Res; 1990 Jun; 66(6):1729-37. PubMed ID: 2344671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmented endothelium-dependent constriction to hypoxia early and late following reperfusion of the canine coronary artery.
    Pearson PJ; Lin PJ; Schaff HV; Vanhoutte PM
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):634-41. PubMed ID: 8886481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1991 Nov; 259(2):490-4. PubMed ID: 1719191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capillary reperfusion after L-arginine, L-NMMA, and L-NNA treatment in cheek pouch microvasculature.
    Bertuglia S; Colantuoni A; Intaglietta M
    Microvasc Res; 1995 Sep; 50(2):162-74. PubMed ID: 8538497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
    Reif DW; McCreedy SA
    Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion].
    Puybasset L; Béa ML; Simon L; Ghaleh B; Giudicelli JF; Berdeaux A
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1217-21. PubMed ID: 8572877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-NAME enhances pulmonary vasoconstriction without inhibiting EDRF-dependent vasodilation.
    Lippton HL; Hao Q; Hyman A
    J Appl Physiol (1985); 1992 Dec; 73(6):2432-9. PubMed ID: 1490955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of N-nitro-L-arginine on coronary artery tone and reactive hyperemia after brief coronary occlusion in conscious dogs.
    Muramatsu K; Numaguchi K; Egashira K; Takahashi T; Kasuya H; Takeshita A
    Coron Artery Dis; 1994 Oct; 5(10):815-20. PubMed ID: 7866601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.